PIK3CA c.869A>G ;(p.K290R)

Variant ID: 3-178921387-A-G

NM_006218.2(PIK3CA):c.869A>G;(p.K290R)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL.

Oncotarget
Takita, Morichika M; Tsukahara, Fujiko F; Mishima, Taishi T; Ieguchi, Katsuaki K; Yamada, Masayuki M; Honda, Hiroaki H; Maru, Yoshiro Y
Publication Date: 2018-08-03

Variant appearance in text: PI3K: K290R
PubMed Link: 30167087
Variant Present in the following documents:
  • Main text
  • oncotarget-09-31682.pdf
View BVdb publication page



Methylation by Set9 modulates FoxO3 stability and transcriptional activity.

Aging
Calnan, Daniel R DR; Webb, Ashley E AE; White, Jamie L JL; Stowe, Timothy R TR; Goswami, Tapasree T; Shi, Xiaobing X; Espejo, Alexsandra A; Bedford, Mark T MT; Gozani, Or O; Gygi, Steven P SP; Brunet, Anne A
Publication Date: 2012-07

Variant appearance in text: PI3K: K290R
PubMed Link: 22820736
Variant Present in the following documents:
  • Main text
  • aging-04-462.pdf
View BVdb publication page



Reciprocal regulation of Abl and receptor tyrosine kinases.

Cellular Signalling
Srinivasan, Divyamani D; Kaetzel, David M DM; Plattner, Rina R
Publication Date: 2009-07

Variant appearance in text: PI3K: K290R
PubMed Link: 19275932
Variant Present in the following documents:
  • Main text
View BVdb publication page